TBIO TELESIS BIO
- 5.500
- +1.280+30.33%
- 5.460
- -0.040-0.73%
TELESIS BIO News
4: Statement of changes in beneficial ownership of securities-Director Krueger Todd
4: Statement of changes in beneficial ownership of securities-Director Hodges Michael R.
4: Statement of changes in beneficial ownership of securities-Director Hlavinka Sarah E.
4: Statement of changes in beneficial ownership of securities-Director Golub Steven J
4: Statement of changes in beneficial ownership of securities-Director Weissman James B
3: Initial statement of beneficial ownership of securities-Director Krueger Todd
3: Initial statement of beneficial ownership of securities-Director Golub Steven J
3: Initial statement of beneficial ownership of securities-Director Hlavinka Sarah E.
3: Initial statement of beneficial ownership of securities-Director Weissman James B
3: Initial statement of beneficial ownership of securities-Director Hodges Michael R.
SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Michael P. Rubin(47.7%),Northpond Ventures, LP(46.5%), etc.
SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Novalis LifeSciences Investments II, L.P.(19.99%),Novalis LifeSciences Investments II GP, LLC(19.99%), etc.
8-K: Current report
8-K: Current report
SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Michael P. Rubin(47.6%),Northpond Ventures, LP(46.4%), etc.
SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Novalis LifeSciences Investments II, L.P.(19.99%),Novalis LifeSciences Investments II GP, LLC(19.99%), etc.
10-Q: Quarterly report
8-K: Telesis Bio Reports First Quarter 2024 Financial Results
8-K: Current report
4: Statement of changes in beneficial ownership of securities-Director Witney Frank
Analysis
Price Target
No Data
